Pharmacogenomics

Pharmacogenomics is a piece of a field called customized solution that means to tweak human services, with choices and medications custom-made to every individual patient inside and out conceivable. Pharmacogenomics and pharmacogenomics manage new developments in the field of customized meds and advancements in modified medication revelation utilizing proteome innovation.

Pharmacogenomics aims to customize health care, with decisions and treatments tailored to each individual patient in every way possible. Genomic testing is still a relatively new development in drug treatment, this field is expanding. Currently, more than 100 drugs have label information regarding pharmacogenomics biomarkers. This information is used to improve the selection and dosage of drugs to treat a wide range of conditions, including cardiovascular disease, lung disease, HIV infection, cancer, arthritis, high cholesterol and depression.


  • Pharmacotherapy
  • Pharmacokinetics
  • Personalized Medicine
  • Drug-metabolizing enzymes

Related Conference of Pharmacogenomics

April 16-17, 2026

19th World Congress on Stem Cell Research

Tokyo, Japan
June 08-09, 2026

9th Global Conference on Cell and Gene Therapy

Rome, Italy
June 15-16, 2026

22nd Global Summit on Stem Cell & Regenerative Medicine

Amsterdam, Netherlands
June 15-16, 2026

13th World Congress on Epigenetics and Chromosome

Paris, France
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 25-26, 2025

6th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in